Hemodynamic effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension

Chest. 1998 Jul;114(1 Suppl):17S. doi: 10.1378/chest.114.1_supplement.17s.

Authors

D D Ivy¹, J W Ziegler, J P Kinsella, J W Wiggins, S H Abman

Affiliation

¹ Pediatric Heart Lung Center, Department of Pediatrics, University of Colorado School of Medicine, and The Children's Hospital, Denver, USA.

PMID: 9676605
DOI: 10.1378/chest.114.1_supplement.17s

No abstract available

MeSH terms

Administration, Inhalation
Child
Dipyridamole / pharmacology*
Heart Defects, Congenital / physiopathology
Heart Defects, Congenital / surgery
Hemodynamics / drug effects
Humans
Hypertension, Pulmonary / drug therapy
Hypertension, Pulmonary / physiopathology*
Nitric Oxide / pharmacology*
Nitric Oxide / therapeutic use
Postoperative Period
Vasodilation / drug effects*

Substances

Nitric Oxide
Dipyridamole